Brain stem cell injection trial launches for rare Parkinson's-Like disease
NCT ID NCT07617012
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether injecting special stem cells into the brain is safe for people with a rare, severe movement disorder called MSA-P. Only 3 participants will receive the treatment, and the main goal is to check for serious side effects within the first month. This is not a cure, but a first step toward possibly controlling the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY PARKINSONIAN VARIANT (MSA-P) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.